Chamasha Himani Kapuruge 2025 Joint Meeting of the COSA ASM and IPOS Congress

Abstracts this author is presenting:

• Real world use of Durvalumab post CRT in stage III NSCLC compared to PACIFIC-R: Barriers to uptake and completion — Afternoon tea, Poster session 1 & Exhibition